Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Kevin Bercimuelle-Chamot, Jocelyn Bosse, Alessandro Cerri, Anastasiia Kyrylenko, Marcel Pemsel and Anna Maria Stein.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Antonios Baris (Book Review Editor), Rose Hughes (PatKat) and Chijioke Okorie (Africa Correspondent).

InternKats: Asude Sena Moya and Söğüt Atilla.
Home / competition law / events / IPKat readers / pharmaceutical industry / "Competition Law in the Pharmaceutical Sector" returns to Brussels with IPKat readers’ discount

"Competition Law in the Pharmaceutical Sector" returns to Brussels with IPKat readers’ discount

- , , ,
Pharma Kat

The IPKat has learned that the conference, organized by InformaConnect, on “Competition Law in the Pharmaceutical Sector” will return to Brussels on 5 December.

This year’s programme, which features 27 speakers (from the European Commission, Novartis, GSK, Linklaters, Johnson & Johnson, and more), will cover developments affecting the sector, including intensifying enforcement initiatives from the competition authorities, patent investigations and fines, and new merger developments.

According to the organizers, this is the only European conference focussing specifically on competition law in the pharma sector.

The IPKat has negotiated a 15% discount in the registration fee for IPKat readers using FKW83533IPKE at checkout.

For further information and to register, click here.
"Competition Law in the Pharmaceutical Sector" returns to Brussels with IPKat readers’ discount "Competition Law in the Pharmaceutical Sector" returns to Brussels with IPKat readers’ discount Reviewed by Eleonora Rosati on Thursday, October 26, 2023 Rating: 5

No comments:

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html

Subscribe to: Post Comments ( Atom )
Powered by Blogger.